Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus
discussions in diabetes
Contributor
Steven Edelman, MD
Steven Edelman, MD
Clinical Professor of Medicine
University of California, San Diego School of Medicine
San Diego, California
Contributor
Jane Jeffrie Seley, DNP, MPH, BC-ADM, CDE
Jane Jeffrie Seley, DNP, MPH, BC-ADM, CDE
Diabetes Nurse Practitioner,
Certified Diabetes Educator
New York-Presbyterian/Weill Cornell Medical Center
New York, New York
Contributor
Ian Blumer, MD
Ian Blumer, MD
Medical Director, Charles H. Best Diabetes Centre
Lecturer, University of Toronto
Toronto, Canada
Contributor
Jeremy Pettus, MD
Jeremy Pettus, MD
Endocrinology Fellow
University of California, San Diego
San Diego, California
Steven Edelman, MD and Robert Henry, MD explain the clinical characteristics that would lead to the use of a DPP-4 inhibitor versus a GLP-1 receptor agonist. They discuss the drugs’ different effects on weight and how patients’ duration of...
This month in Discussions in Diabetes, Steven Edelman, MD, and Robert Henry, MD, discuss how physicians can use incretins to help patients with type 2 diabetes reach their glycemic goals and other metabolic parameters. They explain how incretins relate to...
This month in Discussions in Diabetes, Steve Edelmen, MD, and Jeremy Pettus, MD, delve into continuous glucose monitoring, a new innovation for patients with Type 1 and Type 2 diabetes that allows for constant measuring of blood sugar levels. They explain...